NCT03854227 2025-01-13A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid TumorsPfizerPhase 1 Terminated54 enrolled 42 charts
NCT04747470 2024-09-03Study to Assess the Effects of GS-3583 in Participants With Advanced Solid TumorsGilead SciencesPhase 1 Terminated13 enrolled 18 charts